XISTA Science Ventures
VC Fund
Klosterneuburg, Austria
XISTA Science Ventures is a VC fund in Klosterneuburg focused on Biotechnology and Medical. We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
- Total investments:
- 47
- Last investment:
- Lead investor:
- 57%
Last updated:
For AI agents: llms.txt
Industries XISTA Science Ventures invests in
Stages XISTA Science Ventures invests in
Countries XISTA Science Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 9 contacts → | |||
Round size
- Seed
- $1.8M–$6.9M
- Pre-Seed
- $548k–$1.7M
- Series A
- $5.7M–$20M
Investment Focus
Industry
- Biotechnology 9 (19%)
- Medical 4 (9%)
- Software 3 (6%)
- Health Care 3 (6%)
- Medical Device 3 (6%)
Stage
- Seed 16 (34%)
- Pre-Seed 13 (28%)
- Series A 6 (13%)
- Venture - Series Unknown 1 (2%)
Country
- Austria 15 (32%)
- Germany 3 (6%)
- France 1 (2%)
- Slovenia 1 (2%)
- Philippines 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alexander Fischl
Tech Transfer Associate
|
Tech Transfer Associate | Total investments: 0 | Find email | |
Alexander Schwartz
Partner
|
Partner | Total investments: 13 | Find email | |
Markus Wanko
Founder and Managing Partner
|
Founder and Managing Partner | Total investments: 8 | Find email | |
Stephan Huber
Venture Partner
|
Venture Partner | Total investments: 1 | Find email | |
Bernhard Petermeier
Partner
|
Partner | Total investments: 2 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology. | $2.3M / Seed / Jul 10, 2026 | ||
| Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity. | $2.3M / Pre-Seed / Jun 30, 2026 | ||
| Ora Computing is an AI infrastructure startup focused on compressing and optimizing large AI models, especially Large Language Models (LLMs), to make them cheaper and more efficient to deploy. | $4M / Seed / Jun 24, 2026 | ||
| CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer. | $6.9M / Seed / Jun 12, 2026 | ||
| Invisible Light Labs uses Fourier transform infrared (FTIR) spectroscopy and nanoelectromechanical sensing technologies to enable chemical analysis of materials and nanomaterials that are available in minuscule amounts in a variety of industries, from environmental monitoring to pharmaceuticals. | $1.7M / Pre-Seed / Jun 09, 2026 | ||
| VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development. | $3.5M / Venture - Series Unknown / Mar 12, 2026 | ||
| Factorymaker designs and analyzes sustainable, cost-efficient industrial layout and building proposals, guiding you through informed decisions at early design stage | $1.3M / Pre-Seed / Feb 19, 2026 | ||
| AVES Reality is a company that creates AI-based software that generates virtual 3D maps of any location using data such as satellite and overflight images. | $3.1M / Seed / Jan 14, 2026 | ||
| Inspired by quantum technology, VitreaLab provides integrated optics solutions ranging from lighting to visionary displays products. | $11M / Series A / Jan 07, 2026 | ||
| Amplifold is a biotech/medtech business that is developing next-generation quick diagnostic tests using DNA origami nanotechnology. | $5.9M / Seed / Dec 10, 2025 | ||
| See all 47 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does XISTA Science Ventures invest in?
XISTA Science Ventures invests primarily in Biotechnology, Medical and Software startups, most often at Seed and Pre-Seed stage. Most of the 47 investments tracked by Shizune back companies in Austria. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is XISTA Science Ventures's check size?
XISTA Science Ventures typically joins rounds of $1.8M–$6.9M at Seed, $548k–$1.7M at Pre-Seed and $5.7M–$20M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds XISTA Science Ventures participates in.
How do I contact XISTA Science Ventures?
Public channels for XISTA Science Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at XISTA Science Ventures?
The team at XISTA Science Ventures includes Alexander Fischl (Tech Transfer Associate), Alexander Schwartz (Partner) and Markus Wanko (Founder and Managing Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
